137 related articles for article (PubMed ID: 901052)
1. [Renin-angiotensin-aldosterone system in the treatment of essential hypertension with a beta-adrenergic blocker: sotalol].
Psadas C; Sánchez G; Zaldívar HM; Rangel J; Cuéllar A; Serrano PA
Arch Inst Cardiol Mex; 1977; 47(2):160-70. PubMed ID: 901052
[TBL] [Abstract][Full Text] [Related]
2. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
3. [Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives].
Vetter H; Zumkley H; Glänzer K; Witassek F; Wollnik S; Vetter W
Schweiz Med Wochenschr; 1980 Dec; 110(50):1938-41. PubMed ID: 7010579
[TBL] [Abstract][Full Text] [Related]
4. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
5. Effect of sotalol on haemodynamics and renin-angiotensin-aldosterone system in hypertensive patients.
Verniory A; Staroukine M; Delwiche F; Telerman M
Clin Sci Mol Med; 1976 Jul; 51(1):9-17. PubMed ID: 939070
[TBL] [Abstract][Full Text] [Related]
6. [Is there a relation between the renin-angiotensin-aldosterone system and vasopressin secretion in essential hypertension?].
Wiecek A; Kokot F
Z Gesamte Inn Med; 1984 Dec; 39(23):578-82. PubMed ID: 6396982
[TBL] [Abstract][Full Text] [Related]
7. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
Marzecka J
Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-aldosterone system in five subtypes of essential hypertension.
Cugini P; Manconi R; Mancini A; Serdoz R; Meucci T; Scavo D
G Ital Cardiol; 1980; 10(2):184-90. PubMed ID: 6102942
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
Hauger-Klevene JH
Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
[TBL] [Abstract][Full Text] [Related]
10. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
11. [The renin-angiotensin-aldosterone system in hypertensive subjects. I-Analytical study of 124 patients (author's transl)].
Corvol P; Houde M; Menard J; Milliez P
Nouv Presse Med; 1977 Aug 27-Sep 3; 6(28):2483-7. PubMed ID: 917787
[TBL] [Abstract][Full Text] [Related]
12. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
Ocón J; Mora-Macià J; Castellet R; del Río G
Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
[TBL] [Abstract][Full Text] [Related]
13. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of arterial hypertension with sotalol, a beta-blocker (author's transl)].
Klein G; Schnelle K; Schinz A; Oberländer V
Dtsch Med Wochenschr; 1977 Apr; 102(15):563-9. PubMed ID: 849711
[TBL] [Abstract][Full Text] [Related]
15. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A
G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
17. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers].
Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M
Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357
[TBL] [Abstract][Full Text] [Related]
18. [Effect of coffee on blood pressure and activity renin-angiotensin- aldosterone system and catecholamines concentration in patients with essential hypertension].
Mazurek W; Negrusz-Kawecka M
Pol Merkur Lekarski; 1999 Oct; 7(40):159-63. PubMed ID: 10835904
[TBL] [Abstract][Full Text] [Related]
19. Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.
Taylor AA; Mitchell JR; Bartter FC; Snodgrass WR; McMurtry RJ; Gill JR; Franklin RB
J Clin Invest; 1978 Jul; 62(1):162-8. PubMed ID: 149141
[TBL] [Abstract][Full Text] [Related]
20. [Changes in the renin-angiotensin-aldosterone system during graduated ergometric tests in patients with essential arterial hypertension and in normal controls].
Marchezotti AV; Feldstein CA; Leber B; Burucúa JE; Vilches AM; Varela de Rodríguez J
Rev Clin Esp; 1981 May; 161(3):145-8. PubMed ID: 7022582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
